SMART
2018
Isotonic Solutions and Major Adverse Renal Events Trial
In 15,802 ICU patients, balanced crystalloids reduced the composite of major adverse kidney events at 30 days versus saline.
Result
Efficacy: MAKE30 (death, RRT or persistent renal dysfunction)OR 0.91 · P = 0.04
Below 1 favours balanced crystalloids, above 1 favours saline.
- Absolute difference
- 1.1 points
- NNT
- 91
Absolute difference and NNT are derived from the event rates.
- Subtopic
- Balanced crystalloids
- Design
- Cluster-randomised crossover trial, Vanderbilt
- Relevance
- Important: one of several pillars.
- Source
- Semler MW, et al. N Engl J Med. 2018;378(9):829-839.doi 10.1056/NEJMoa1711584
Discussion & critique
Small absolute effect but a defensible default for balanced solutions in non-TBI ICU patients.
Discussed in podcasts
- Freely Filtered, a NephJC Podcast · 3 episodes, latest 28 Feb 2024 (Show website)
- The Skeptics Guide to Emergency Medicine · 2 episodes, latest 12 Jun 2022 (Listen)On Trialsgram
- Core IM | Internal Medicine Podcast · #103 Fluids: 5 Pearls Segment · 27 Apr 2022 (Listen)
- Critical Care Reviews Podcast · 4 episodes, latest 22 Feb 2022 (Show website)On Trialsgram
- This Week in Cardiology · Episode 41 · 2 Mar 2018 (Listen)